Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Urology, Nephrology and Andrology International

Volume  1, Issue 2, July - December 2016, Pages 61-66
 

Original Article

Role of PSA in Diagnosing Carcinoma Prostate in India: Is the Situation Same as in Developed Countries

Sanjay P. Dhangar*, Rajeev R. Chaudhari**, Ibrahim H. Kothawala***, Sahil Khant****

*Urologist and Assistant Professor, Department of Surgery, SMBT Institute of Medical Sciences and Research Centre, Nandi Hills, Dhamangao, Ghoti, Tal-Igatpuri, Distt.—Nashik, Maharashtra. **Senior Consultant Urologist ****Resident, Ruby Hall Clin

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: N/A

Abstract

 Background: Prostate cancer has become the single most common non-cutaneous malignancy in men. Its incidence has been rising rapidly in most countries including low risk countries like India. Present study deals with the PSA value in patients with prostatic symptoms and its correlation with the prostatic biopsy specimen. Purpose: (i) Co-relation of raised PSA in non- carcinoma prostate patients. (ii) At what stage does carcinoma of prostate gets diagnosed in Indian scenario. (iii) What are the treatment options opted by the patients who are diagnosed with carcinoma of prostate for the first time. Materials and Methods: First 500 patients that presented with lower urinary tract symptoms and prostatic enlargement through the casualty department, outpatient department and in patient department of the Department of Urology, Ruby Hall Clinic, Pune from March 2012 to February 2014 were included in the present study.Prostatic biopsy was done in cases with either increased serum PSA level and/or palpable nodule and/or suspicious TRUS findings or a combination of two out of these 3 factors. Results: Mean PSA value is 8.5ng/ml in BPH patients, indicating higher values in Indian patients, due to prostatitis.Maximum carcinoma prostate patients presented late with metastases. As the limit of PSA value for diagnosis of carcinoma prostate increases from 4ng/ ml to 15ng/ml the sensitivity decreases and the specificity and diagnostic accuracy increases.The patients of carcinoma prostate received treatment as per their stage of presentation. Conclusion: In Indian context there is an overall baseline elevation of lower minimum level of the normal PSA.This is probably due to association of prostatitis in Indian population.

Keywords: BPH; Carcinoma Prostate in India; Chronic Prostatitis; PSA


Corresponding Author : Sanjay P. Dhangar*